Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the ...

which was presented by the Materials Chemistry Community Programme Manager, Philip Stackhouse. Delegates and conference organisers praised the high quality of oral and poster presentations, the ...

Enliven's discovery process combines deep insights in clinically validated biological targets and differentiated chemistry to ... therapeutics-announces-poster-presentations-at-the-2025-aacr ...